Bast D J, Sandhu J, Hozumi N, Barber B, Brunton J
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Department of Microbiology, University of Toronto, Ontario, Canada.
Infect Immun. 1997 Jul;65(7):2978-82. doi: 10.1128/iai.65.7.2978-2982.1997.
Structurally conserved verotoxin 1 (VT1) mutant derivatives, showing reduced receptor binding and cytotoxicity, may serve as natural toxoids to protect against VT-mediated disease. In this study, the antibody responses to the wild-type VT1 B subunit, a B-subunit mutant (Phe30Ala B), and the corresponding holotoxin (Phe30Ala HT) were examined in three inbred mouse strains. BALB/c (H-2d) and CBA (H-2k) mice produced strong antibody responses to both wild-type and mutant B subunits. VT1 B-raised sera reacted more strongly with VT1 B than with Phe30Ala B in enzyme-linked immunosorbent assays, while Phe30Ala B-raised sera reacted equally with VT1 B and Phe30Ala B. C57BL/6 (H-2b) and congenic BALB/c (BALB x B [H-2b]) mice produced no detectable antibody response to either VT1 B or Phe30Ala B. However, an anti-VT1 B antibody response was detected in H-2b mice immunized with biologically active Phe30Ala HT. Based on these observations, we conclude that the VT1 B subunit possesses a B-cell immunodominant epitope formed partly by phenylalanine 30 and that the B-subunit antibody response is dependent on the H-2 haplotype of the mouse strain. Our results also support a potential role for the A subunit in providing the T-cell help necessary to overcome a deficient B-subunit antibody response in H-2b mice.
结构保守的志贺毒素1(VT1)突变衍生物,其受体结合能力和细胞毒性降低,可作为天然类毒素用于预防VT介导的疾病。在本研究中,检测了三种近交系小鼠对野生型VT1 B亚基、一种B亚基突变体(Phe30Ala B)和相应全毒素(Phe30Ala HT)的抗体反应。BALB/c(H-2d)和CBA(H-2k)小鼠对野生型和突变型B亚基均产生强烈的抗体反应。在酶联免疫吸附试验中,用VT1 B免疫产生的血清与VT1 B的反应比与Phe30Ala B的反应更强,而用Phe30Ala B免疫产生的血清与VT1 B和Phe30Ala B的反应相同。C57BL/6(H-2b)和同源BALB/c(BALB x B [H-2b])小鼠对VT1 B或Phe30Ala B均未产生可检测到的抗体反应。然而,在用生物活性Phe30Ala HT免疫的H-2b小鼠中检测到了抗VT1 B抗体反应。基于这些观察结果,我们得出结论,VT1 B亚基具有一个部分由苯丙氨酸30形成的B细胞免疫显性表位,并且B亚基抗体反应依赖于小鼠品系的H-2单倍型。我们的结果还支持A亚基在提供克服H-2b小鼠中B亚基抗体反应缺陷所需的T细胞辅助方面的潜在作用。